Immunic, Inc

(NASDAQ:IMUX)

Latest On Immunic, Inc (IMUX):

Date/Time Type Description Signal Details
2023-05-16 00:53 ESTNewsImmunic: Proof Of Concept With IMU-856 Provides Additional Shot On GoalN/A
2023-05-14 21:40 ESTNewsImmunic, Inc. (IMUX) Q1 2023 Earnings Call TranscriptN/A
2023-05-11 20:55 ESTNewsImmunic GAAP EPS of -$0.58 misses by $0.06N/A
2023-05-09 00:52 ESTNewsImmunic gains after early-stage data for bowel disease candidateN/A
2023-05-04 13:06 ESTNewsImmunic's celiac disease drug shows promise in ongoing phase 1 trialN/A
2023-04-05 23:34 ESTNewsImmunic surges ~20% as IMU-838 shows promise in ulcerative colitis trialN/A
2023-02-23 15:53 ESTNewsImmunic GAAP EPS of -$3.78 misses by $0.88N/A
2023-02-23 15:52 ESTNewsImmunic, Inc. (IMUX) Q4 2022 Earnings Call TranscriptN/A
2023-02-22 14:01 ESTNewsImmunic FY 2022 Earnings PreviewN/A
2023-02-07 20:13 ESTNewsImmunic: Multiple Sclerosis Data In H2 2023 Could Provide Major ShiftN/A
2023-01-31 16:39 ESTNewsImmunic adds 14% as Wedbush initiates with bullish view on lead assetN/A
2022-12-28 13:41 ESTNewsImmunic: Revisiting A 'Lottery Ticket'N/A
2022-11-17 22:38 ESTNewsImmunic rises 15% as drug prevents/delays worsening of MS patients in long term trial dataN/A
2022-11-06 09:01 ESTNewsImmunic, Inc. (IMUX) Q3 2022 Earnings Call TranscriptN/A
2022-11-03 10:34 ESTNewsImmunic GAAP EPS of -$0.69 misses by $0.03N/A
2022-11-02 18:42 ESTNewsImmunic Q3 2022 Earnings PreviewN/A
2022-10-20 17:37 ESTNewsImmunic sinks ~74% after hours as phase 1b psoriasis trial fails to separate from placeboN/A
2022-10-12 21:36 ESTNewsImmunic: New MS Drugs Need Extreme Product DifferentiationN/A
2022-10-10 13:26 ESTNewsImmunic stock gains on $60M oversubscribed PIPE financingN/A
2022-08-07 02:12 ESTNewsImmunic, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-07 02:12 ESTNewsImmunic, Inc. (IMUX) CEO Daniel Vitt on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 12:26 ESTNewsImmunic GAAP EPS of -$0.72 in-lineN/A
2022-06-15 10:02 ESTNewsImmunic rises on publication of trial results for lead asset in multiple sclerosisN/A
2022-06-02 10:09 ESTNewsImmunic stock crashes 62% as lead asset IMU-838 fails mid-stage study in ulcerative colitisN/A
2022-05-12 00:35 ESTNewsImmunic, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-11 04:51 ESTNewsImmunic Inc. (IMUX) CEO Daniel Vitt on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 07:12 ESTNewsImmunic GAAP EPS of -$0.74 beats by $0.05N/A
2022-03-17 12:03 ESTNewsImmunic promotes internal candidate to CFO roleN/A
2022-02-24 13:55 ESTNewsImmunic GAAP EPS of -$3.93 misses by $0.04N/A
2022-02-24 13:55 ESTNewsImmunic, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-24 13:55 ESTNewsImmunic Inc. (IMUX) CEO Daniel Vitt on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-23 18:55 ESTNewsImmunic FY 2021 Earnings PreviewN/A
2021-11-06 22:00 ESTNewsImmunic, Inc. (IMUX) CEO Daniel Vitt on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-04 10:47 ESTNewsImmunic EPS beats by $0.02N/A
2021-11-02 17:41 ESTNewsWarning: IMUX is at high risk of performing badlyN/A
2021-10-28 23:19 ESTNewsImmunic completes enrollment in mid-stage IMU-838 ulcerative colitis studyN/A
2021-10-14 19:42 ESTNewsImmunic hires Patrick Walsh as Chief Business OfficerN/A
2021-09-30 16:30 ESTNewsEnrollment underway in Immunic's mid-stage study of IMU-838 in progressive multiple sclerosisN/A
2021-09-23 04:56 ESTNewsImmunic inks license deal for DHODH inhibitors in viral infections, including COVID-19N/A
2021-08-07 01:16 ESTNewsImmunic EPS misses by $0.15N/A
2021-07-21 11:54 ESTNewsImmunic stock gains 6% on FDA go ahead for IMU-838 trials in multiple sclerosisN/A
2021-07-21 11:48 ESTNewsImmunic announces common stock public offeringN/A
2021-07-21 11:48 ESTNewsRFIL, KC, IMUX and GBS among after-hours moversN/A
2021-07-21 11:48 ESTNewsImmunic slips on pricing $45M equity offeringN/A
2021-07-21 11:47 ESTNewsImmunic (IMUX) Updates On The Preclinical And Clinical Development Of IMU-935 - SlideshowN/A
2021-05-06 13:45 ESTNewsImmunic EPS misses by $0.95N/A
2021-03-17 02:00 ESTNewsImmunic (IMUX) Presents At 33rd Annual Roth ConferenceN/A
2021-03-01 11:47 ESTEarnings EstimateAn EPS average of -$3.20 is estimated for the 2022 year.Sell
2021-03-01 11:47 ESTEarnings EstimateAn EPS average of -$0.65 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-28 11:52 ESTFinancialsCompany financials have been released.Neutral

About Immunic, Inc (IMUX):

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.

IMUX Quotes by TradingView

See Advanced Chart

General

  • Name Immunic, Inc
  • Symbol IMUX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 28
  • Last Split Factor1:40
  • Last Split Date2019-04-15
  • Fiscal Year EndDecember
  • IPO Date2014-04-17
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.immunic-therapeutics.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2.04
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.89
  • Next Year EPS Estimate -$3.67
  • Next Quarter EPS Estimate -$0.63
  • Return on Assets -26%
  • Return on Equity -41%
  • Earnings Per Share -$11.31
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 320.91 million
  • EBITDA -18572000
  • Analyst Target Price $60.83
  • Book Value Per Share $7.50
View More

Share Statistics

  • Shares Outstanding 21.17 million
  • Shares Float 14.34 million
  • % Held by Insiders 2795%
  • % Held by Institutions 46.78%
  • Shares Short 1.31 million
  • Shares Short Prior Month 897720
  • Short Ratio 3.9
  • Short % of Float 9%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • 52 Week High $28.21
  • 52 Week Low $4.9
  • 50 Day Moving Average 17.33
  • 200 Day Moving Average 17.52
View More

Dividends

  • Dividend Date 2019-04-15
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Immunic, Inc (IMUX) Dividend Calendar:

IMUX's last dividend payment was made to shareholders on April 15, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Immunic, Inc (IMUX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-26$N/A-$0.46-$0.6225.2%
2020-09-302020-11-05$N/A-$0.70-$0.65-8.24%
2020-06-302020-08-02$N/A-$0.90-$0.73-23.85%
2020-03-312020-05-08$N/A-$0.79-$0.9617.28%
2019-12-312020-03-16$N/A-$0.75-$0.761.32%
2019-09-302019-11-07$N/A-$0.82-$0.65-26.15%
2019-06-302019-08-08$N/A-$1.52-$0.68-123.53%
2019-03-312019-06-21$N/A-$8.69-$0.59-1372.25%
2018-12-312019-03-04$N/A-$2.33
2018-09-302018-11-07$N/A-$11.20-$11.200%
2018-06-302018-08-07$N/A-$12.00-$13.209.09%
2018-03-312018-05-08$N/A-$13.60-$13.600%
2017-12-312018-03-13$N/A-$14.00-$12.40-12.9%
2017-09-302017-10-25$N/A-$12.00-$12.806.25%
2017-06-302017-08-03$N/A-$11.60-$14.1317.91%
2017-03-312017-05-09$N/A-$15.60-$14.60-6.85%
2016-12-312017-03-07$N/A-$0.37-$0.35-5.71%
2016-09-302016-11-03$N/A-$0.32-$0.320%
2016-06-302016-08-02$N/A-$0.30-$0.339.09%
2016-03-312016-05-09$N/A-$0.31-$0.28-10.71%
2015-12-312016-03-08$N/A-$0.34-$0.4219.05%
2015-09-302015-11-05$N/A-$0.51-$0.5812.07%
2015-06-302015-07-30$N/A-$0.63-$0.62-1.61%
2015-03-312015-05-12$N/A-$0.62-$0.620%
2014-12-312015-03-19$N/A-$0.59-$0.58-1.72%
2014-09-302014-11-13$N/A-$0.59-$0.636.35%
2014-06-302014-08-06$N/A-$36.40-$22.02-65.3%
2014-03-312014-05-29$N/A-$979.60-$20.78-4614.15%

Immunic, Inc (IMUX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Immunic, Inc (IMUX) Chart:

Immunic, Inc (IMUX) News:

Below you will find a list of latest news for Immunic, Inc (IMUX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Immunic, Inc (IMUX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50.1CALL22 18279.64FALSE0.10
2024-05-1750CALL0 00FALSE00
2024-05-177.50CALL0 00FALSE00
2024-05-172.50PUT0 0366.53TRUE00
2024-05-1750PUT0 0514.73TRUE00
2024-05-177.50PUT0 0490.27TRUE00
2024-06-212.50.1CALL1 0175.35FALSE0.10
2024-06-2150CALL0 00FALSE00
2024-06-217.50CALL0 00FALSE00
2024-06-212.50PUT0 0403.64TRUE00
2024-06-2150PUT0 0272.23TRUE00
2024-06-217.50PUT0 0514.92TRUE00
2024-07-192.50.05CALL0 3330FALSE00
2024-07-1950.07CALL0 50FALSE00
2024-07-197.50CALL0 00FALSE00
2024-07-192.51.19PUT0 33102.68TRUE00
2024-07-1950PUT0 0363.88TRUE00
2024-07-197.50PUT0 0299.04TRUE00
2024-10-182.50.05CALL122 479.24FALSE0.050
2024-10-1850.13CALL0 10FALSE00
2024-10-187.50CALL0 00FALSE00
2024-10-182.51.3PUT0 178.64TRUE00
2024-10-1850PUT0 0249.35TRUE00
2024-10-187.50PUT0 0254.34TRUE00
2025-01-170.50CALL0 00TRUE00
2025-01-1710.45CALL0 884158.11TRUE00
2025-01-171.50.43CALL0 554144.37FALSE00
2025-01-1720.2CALL0 255118.85FALSE00
2025-01-172.50.2CALL0 5070FALSE00
2025-01-1730.2CALL0 8280FALSE00
2025-01-173.51.15CALL0 10FALSE00
2025-01-1740.11CALL0 1660FALSE00
2025-01-174.50.15CALL0 1970FALSE00
2025-01-170.50PUT0 00FALSE00
2025-01-1710.2PUT0 60294.27FALSE00
2025-01-171.50.5PUT3 115785.17TRUE00
2025-01-1720.9PUT0 91888.66TRUE00
2025-01-172.51.3PUT0 44586.8TRUE00
2025-01-1731.8PUT0 25781.54TRUE00
2025-01-173.52.25PUT0 8170.88TRUE00
2025-01-1742.7PUT0 57193.3TRUE00
2025-01-174.50PUT0 0145.58TRUE00
2025-06-202.50.2CALL0 230FALSE00
2025-06-2050CALL0 00FALSE00
2025-06-207.50CALL0 00FALSE00
2025-06-202.51.3PUT0 1105TRUE00
2025-06-2050PUT0 0146.19TRUE00
2025-06-207.50PUT0 0333.91TRUE00

Latest IMUX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST7$3.125
Jun 13, 2022 7:59 PM EST68$3.125
Jun 13, 2022 7:59 PM EST12$3.125
Jun 13, 2022 7:59 PM EST345$3.125
Jun 13, 2022 7:59 PM EST54$3.125

Immunic, Inc (IMUX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000718/0001193805-20-000718-index.htm
2019-02-13UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1280776/000000000019002243/0000000000-19-002243-index.htm
2019-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1280776/000104018819000044/0001040188-19-000044-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000117184319000159/0001171843-19-000159-index.htm
2019-01-07425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1280776/000117184319000160/0001171843-19-000160-index.htm
2018-09-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1280776/000119312518275754/0001193125-18-275754-index.htm
2019-02-04S-4Registration of securities, business combinationshttps://www.sec.gov/Archives/edgar/data/1280776/000119312519026996/0001193125-19-026996-index.htm
2019-02-06425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1280776/000119312519029598/0001193125-19-029598-index.htm
2019-02-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1280776/000119312519037823/0001193125-19-037823-index.htm
2019-02-14S-4/ARegistration of securities, business combinationshttps://www.sec.gov/Archives/edgar/data/1280776/000119312519039488/0001193125-19-039488-index.htm
2019-02-19424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1280776/000119312519044352/0001193125-19-044352-index.htm
2019-02-26425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1280776/000119312519051970/0001193125-19-051970-index.htm
2019-02-28425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1280776/000119312519057485/0001193125-19-057485-index.htm
2019-03-13DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1280776/000119312519073294/0001193125-19-073294-index.htm
2019-03-14425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1280776/000119312519074766/0001193125-19-074766-index.htm
2019-03-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1280776/000119312519083499/0001193125-19-083499-index.htm
2019-03-25DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1280776/000119312519085255/0001193125-19-085255-index.htm
2019-03-27DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1280776/000119312519088450/0001193125-19-088450-index.htm
2019-04-02425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1280776/000119312519095652/0001193125-19-095652-index.htm
2019-04-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119312519106593/0001193125-19-106593-index.htm
2019-12-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1280776/000119312519321092/0001193125-19-321092-index.htm
2020-09-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1280776/000119312520240090/0001193125-20-240090-index.htm
2019-04-22SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000386/0001193805-19-000386-index.htm
2019-04-22SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000387/0001193805-19-000387-index.htm
2019-04-22SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000388/0001193805-19-000388-index.htm
2019-04-22SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000389/0001193805-19-000389-index.htm
2019-04-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000397/0001193805-19-000397-index.htm
2019-04-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000398/0001193805-19-000398-index.htm
2019-04-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000399/0001193805-19-000399-index.htm
2019-04-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000400/0001193805-19-000400-index.htm
2019-04-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000401/0001193805-19-000401-index.htm
2019-04-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000402/0001193805-19-000402-index.htm
2019-04-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000404/0001193805-19-000404-index.htm
2019-04-23SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000411/0001193805-19-000411-index.htm
2019-04-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000412/0001193805-19-000412-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000554/0001193805-19-000554-index.htm
2019-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000642/0001193805-19-000642-index.htm
2019-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000646/0001193805-19-000646-index.htm
2019-07-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1280776/000119380519000647/0001193805-19-000647-index.htm
2019-07-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000658/0001193805-19-000658-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000670/0001193805-19-000670-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000671/0001193805-19-000671-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000672/0001193805-19-000672-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000673/0001193805-19-000673-index.htm
2019-07-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000674/0001193805-19-000674-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000700/0001193805-19-000700-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000702/0001193805-19-000702-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000717/0001193805-19-000717-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000797/0001193805-19-000797-index.htm
2019-09-20S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000837/0001193805-19-000837-index.htm
2019-10-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380519000898/0001193805-19-000898-index.htm
2019-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380519001337/0001193805-19-001337-index.htm
2019-10-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519001344/0001193805-19-001344-index.htm
2019-10-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519001345/0001193805-19-001345-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380519001401/0001193805-19-001401-index.htm
2019-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380519001458/0001193805-19-001458-index.htm
2019-11-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519001463/0001193805-19-001463-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519001465/0001193805-19-001465-index.htm
2019-12-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380519001898/0001193805-19-001898-index.htm
2019-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380519001904/0001193805-19-001904-index.htm
2019-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380519001914/0001193805-19-001914-index.htm
2020-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000018/0001193805-20-000018-index.htm
2020-01-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000027/0001193805-20-000027-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000028/0001193805-20-000028-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000363/0001193805-20-000363-index.htm
2020-03-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1280776/000119380520000386/0001193805-20-000386-index.htm
2020-04-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000499/0001193805-20-000499-index.htm
2020-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000504/0001193805-20-000504-index.htm
2020-04-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1280776/000119380520000514/0001193805-20-000514-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000519/0001193805-20-000519-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000532/0001193805-20-000532-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000538/0001193805-20-000538-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000567/0001193805-20-000567-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000575/0001193805-20-000575-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000603/0001193805-20-000603-index.htm
2020-06-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1280776/000119380520000677/0001193805-20-000677-index.htm
2020-06-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1280776/000119380520000684/0001193805-20-000684-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000688/0001193805-20-000688-index.htm
2020-06-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000706/0001193805-20-000706-index.htm
2020-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000718/0001193805-20-000718-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000793/0001193805-20-000793-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000794/0001193805-20-000794-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000795/0001193805-20-000795-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000796/0001193805-20-000796-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000797/0001193805-20-000797-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000798/0001193805-20-000798-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000799/0001193805-20-000799-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000800/0001193805-20-000800-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000802/0001193805-20-000802-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000879/0001193805-20-000879-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000880/0001193805-20-000880-index.htm
2020-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000890/0001193805-20-000890-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000918/0001193805-20-000918-index.htm
2020-08-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1280776/000119380520000920/0001193805-20-000920-index.htm
2020-08-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1280776/000119380520000924/0001193805-20-000924-index.htm
2020-08-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1280776/000119380520000959/0001193805-20-000959-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000975/0001193805-20-000975-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520000993/0001193805-20-000993-index.htm
2020-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520001136/0001193805-20-001136-index.htm
2020-09-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1280776/000119380520001154/0001193805-20-001154-index.htm
2020-10-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520001296/0001193805-20-001296-index.htm
2020-10-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000119380520001306/0001193805-20-001306-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000119380520001389/0001193805-20-001389-index.htm
2018-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000128077618000089/0001280776-18-000089-index.htm
2018-09-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000128077618000091/0001280776-18-000091-index.htm
2018-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000128077618000093/0001280776-18-000093-index.htm
2018-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000128077618000095/0001280776-18-000095-index.htm
2018-10-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000128077618000098/0001280776-18-000098-index.htm
2018-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000128077618000100/0001280776-18-000100-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000128077618000103/0001280776-18-000103-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1280776/000128077618000104/0001280776-18-000104-index.htm
2019-01-07425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1280776/000128077619000002/0001280776-19-000002-index.htm
2019-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000128077619000008/0001280776-19-000008-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000128077619000014/0001280776-19-000014-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000128077619000015/0001280776-19-000015-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000128077619000016/0001280776-19-000016-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000128077619000017/0001280776-19-000017-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1280776/000128077619000018/0001280776-19-000018-index.htm
2019-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000128077619000020/0001280776-19-000020-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000128077619000024/0001280776-19-000024-index.htm
2019-03-0410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1280776/000128077619000025/0001280776-19-000025-index.htm
2019-03-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000128077619000027/0001280776-19-000027-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000128077619000030/0001280776-19-000030-index.htm
2019-04-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1280776/000128077619000032/0001280776-19-000032-index.htm
2019-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000128077619000036/0001280776-19-000036-index.htm
2019-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000128077619000039/0001280776-19-000039-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1280776/000128077619000046/0001280776-19-000046-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1280776/000128077619000051/0001280776-19-000051-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1280776/000128077619000056/0001280776-19-000056-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1280776/000128077620000009/0001280776-20-000009-index.htm
2020-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1280776/000128077620000015/0001280776-20-000015-index.htm
2020-08-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1280776/000128077620000024/0001280776-20-000024-index.htm
2020-08-0310-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1280776/000128077620000028/0001280776-20-000028-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1280776/000128077620000035/0001280776-20-000035-index.htm
2019-06-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1280776/000138713119004477/0001387131-19-004477-index.htm
2020-05-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1280776/000138713120004360/0001387131-20-004360-index.htm
2020-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1280776/000138713120007254/0001387131-20-007254-index.htm
2019-02-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1280776/999999999519000279/9999999995-19-000279-index.htm
2020-02-10SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1280776/999999999720000619/9999999997-20-000619-index.htm
2020-03-02SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1280776/999999999720001094/9999999997-20-001094-index.htm

Immunic, Inc (IMUX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immunic, Inc (IMUX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2795%
Institutional Ownership: 4678%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-09-19Douglas Evan GodshallDirectorSell69,375.000.3524,191.060.00https://www.sec.gov/Archives/edgar/data/1280776/000128077618000091/0001280776-18-000091-index.htm
2018-09-25Errol R. HalperinDirectorSell10,000.000.292,900.000.00https://www.sec.gov/Archives/edgar/data/1280776/000128077618000095/0001280776-18-000095-index.htm
2018-09-25Errol R. HalperinDirectorSell89,417.000.2925,939.870.00https://www.sec.gov/Archives/edgar/data/1280776/000128077618000095/0001280776-18-000095-index.htm
2018-09-17Muneer A SatterDirectorSell7,044,777.000.292,054,256.970.00https://www.sec.gov/Archives/edgar/data/1280776/000128077618000089/0001280776-18-000089-index.htm
2020-08-10Glenn WhaleyPFO and PAOBuy1,000.0018.9618,960.001,000.00https://www.sec.gov/Archives/edgar/data/1280776/000119380520000993/0001193805-20-000993-index.htm
2019-12-04Duane NashDirectorSell4,400.006.9630,624.0010,032.00https://www.sec.gov/Archives/edgar/data/1280776/000119380519001904/0001193805-19-001904-index.htm
2018-09-24JEAN JACQUES BIENAIMEDirectorSell26,619.000.308,001.6718,500.00https://www.sec.gov/Archives/edgar/data/1280776/000128077618000093/0001280776-18-000093-index.htm
2019-12-02Duane NashDirectorBuy22,157.0022,362.00https://www.sec.gov/Archives/edgar/data/1280776/000119380519001904/0001193805-19-001904-index.htm
2020-07-21Manfred GroeppelChief Operating OfficerSell650.0015.6210,154.89278,830.00https://www.sec.gov/Archives/edgar/data/1280776/000119380520000880/0001193805-20-000880-index.htm
2020-07-20Manfred GroeppelChief Operating OfficerSell5,000.0014.4472,200.50279,480.00https://www.sec.gov/Archives/edgar/data/1280776/000119380520000880/0001193805-20-000880-index.htm
2020-07-21Daniel VittChief Executive OfficerSell1,300.0015.6220,309.77362,877.00https://www.sec.gov/Archives/edgar/data/1280776/000119380520000879/0001193805-20-000879-index.htm
2020-07-20Daniel VittChief Executive OfficerSell5,000.0014.4472,200.50364,177.00https://www.sec.gov/Archives/edgar/data/1280776/000119380520000879/0001193805-20-000879-index.htm
2018-09-14Muneer A SatterDirectorSell447,500.000.36160,384.007,044,777.00https://www.sec.gov/Archives/edgar/data/1280776/000128077618000089/0001280776-18-000089-index.htm
2018-09-13Muneer A SatterDirectorSell3,890,000.000.501,930,996.007,492,277.00https://www.sec.gov/Archives/edgar/data/1280776/000128077618000089/0001280776-18-000089-index.htm